Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law Amid wellness craze, FDA weighs lifting peptide restrictions The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's Overreach on Compounded Peptides FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner